(Q46130819)

19 December 2017

title

The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro (English)

1 reference

19 December 2017

1 reference

Masayuki Kawashima

1

1 reference

19 December 2017

Yosuke Fujikawa

2

1 reference

19 December 2017

Ichiro Itonaga

3

1 reference

19 December 2017

Chikahiro Takita

4

1 reference

19 December 2017

Hiroshi Tsumura

5

1 reference

19 December 2017

publication date

6 February 2009

1 reference

19 December 2017

published in

Modern Rheumatology

1 reference

19 December 2017

volume

19

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

192-198

1 reference

19 December 2017

Stimulation of arachidonic acid metabolism in primary cultures of osteoblast-like cells by hormones and drugs

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Stimulation of prostaglandin E2 production by interleukin-1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Role of cyclooxygenase-2 in bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

Novel regulatory mechanisms of CD40-induced prostanoid synthesis by IL-4 and IL-10 in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

21 January 2018

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0149-6

10.3109/S10165-008-0149-6

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

release_aobjw25iorcm5klpxvgdfwskuq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aobjw25iorcm5klpxvgdfwskuq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

19 December 2017